David Quinn Selected Research

Heart Failure

1/2021

Pathophysiology of severe primary graft dysfunction in orthotopic heart transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Quinn Research Topics

Disease

10	Neoplasms (Cancer) 07/2023 - 06/2005
6	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 01/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 06/2010
3	Carcinoma (Carcinomatosis) 01/2023 - 11/2013
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014 - 06/2002
2	Circulating Neoplastic Cells 02/2022 - 01/2019
2	Stroke (Strokes) 01/2022 - 01/2021
2	Primary Graft Dysfunction 02/2021 - 01/2021
1	Abdominal Aortic Aneurysm 02/2024
1	Heart Failure 01/2021
1	Adenocarcinoma 06/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Intraoperative Complications 01/2017
1	Transitional Cell Carcinoma 01/2014
1	Carcinogenesis 01/2014
1	Cardiac Papillary Fibroelastoma 09/2013
1	Rupture 01/2011
1	Infections 03/2010
1	Fatigue 12/2009
1	Dizziness (Lightheadedness) 12/2009
1	Mesothelioma 06/2005

Drug/Important Bio-Agent (IBA)

2	pembrolizumabIBA 01/2023 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 01/2019
2	Cell-Free Nucleic AcidsIBA 02/2022 - 01/2019
2	Prostaglandins DIBA 02/2021 - 01/2021
2	EphrinsIBA 06/2020 - 01/2014
2	EphB4 ReceptorIBA 01/2014 - 06/2005
2	Sorafenib (BAY 43-9006)FDA Link 04/2011 - 06/2010
1	N 30IBA 07/2023
1	PlatinumIBA 01/2023
1	Serum AlbuminIBA 01/2023
1	LigandsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2020
1	avelumabIBA 10/2020
1	durvalumabIBA 10/2020
1	NivolumabIBA 10/2020
1	AntibodiesIBA 10/2020
1	atezolizumabIBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Radium-223IBA 09/2020
1	AndrogensIBA 06/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	Acetates (Acetic Acid Esters)FDA Link 01/2017
1	Phosphotransferases (Kinase)IBA 01/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Bevacizumab (Avastin)FDA Link 01/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2013
1	Vinblastine (Vinblastine Sulfate)FDA Link 11/2013
1	Gemcitabine FDA Link 11/2013
1	Methotrexate (Mexate)FDA LinkGeneric 11/2013
1	Cisplatin (Platino)FDA LinkGeneric 11/2013
1	Warfarin (Coumadin)FDA LinkGeneric 09/2013
1	Biomarkers (Surrogate Marker)IBA 03/2011
1	chymostatinIBA 01/2011
1	Serine (L-Serine)FDA Link 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	EGTA acetoxymethyl esterIBA 01/2011
1	EpitopesIBA 03/2010
1	Tumor Biomarkers (Tumor Markers)IBA 12/2009
1	Docetaxel (Taxotere)FDA Link 01/2006
1	sulindac sulfone (exisulind)IBA 01/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2005
1	OligodeoxyribonucleotidesIBA 06/2005

Therapy/Procedure

5	Therapeutics 07/2023 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2023 - 06/2002
2	Heart Transplantation (Grafting, Heart) 02/2021 - 01/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 11/2013
2	Cystectomy 11/2013 - 06/2002
1	Endovascular Aneurysm Repair 02/2024
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Tracheostomy 01/2022
1	Castration 09/2020
1	Sphygmomanometers 01/2019
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Neoadjuvant Therapy 11/2013
1	Prostatectomy (Retropubic Prostatectomy) 01/2011
1	Radiotherapy 06/2002